18 Mar 2026 by admin in UncategorizedComments Alebund Pharmaceuticals Announces Collaboration and License Agreement with R1 Therapeutics for AP306
11 Mar 2026 by admin in UncategorizedComments Tempest Announces Partnership for TPST-2003 in Preparation for Planned U.S. Registrational Study in 2026
